Your browser doesn't support javascript.
loading
CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
Dong, Yongjian; Gao, Shuhui; Zhang, Xuefang; Kou, Jing; Liu, Jing; Ye, Ting; Shen, Han.
Afiliação
  • Dong Y; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong.
  • Gao S; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong.
  • Zhang X; Department of Radiation Oncology, Dongguan People's Hospital, Affiliated Dongguan Hospital of Southern Medical University, Dongguan, Guangdong, China.
  • Kou J; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong.
  • Liu J; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong.
  • Ye T; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong.
  • Shen H; Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, Guangdong.
Anticancer Drugs ; 33(2): 149-157, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34657098
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimiocina CCL17 / Quimiocina CCL22 / Receptores CCR4 / Células Matadoras Induzidas por Citocinas Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimiocina CCL17 / Quimiocina CCL22 / Receptores CCR4 / Células Matadoras Induzidas por Citocinas Limite: Humans Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2022 Tipo de documento: Article